A Review on Diuretic Activity, Pharmacological Uses and Phytochemical studies of Boerhavia diffusa Linn. (Punarnava)

Diuretics are widely prescribed therapeutic agents that help manage hypertension, heart failure, renal disorders, edema, and ascites. By promoting urinary excretion and maintaining fluid and electrolyte balance. These drugs facilitate the elimination of excess body fluids by increasing urine production and promoting electrolyte excretion, thereby helping to maintain fluid homeostasis in the body (George et al., 2014).by increasing urine production, Diuretics help reduce excess body fluid, relieve edema and the risk of cardiovascular and renal complications associated with fluid retention. However, despite their therapeutic importance, prolonged administration of synthetic diuretics such as loop diuretics, thiazides, carbonic anhydrase inhibitors, and potassium-sparing agents frequently results in adverse effects including dehydration, electrolyte imbalance, metabolic alkalosis, hyperuricemia, and nephrotoxicity (Williams et al., 2022). Furthermore, chronic use of these agents may reduce therapeutic effectiveness due to compensatory physiological mechanisms involving activation of the renin-angiotensin-aldosterone system (RAAS) and decreased drug efficacy (Ravindran et al., 2023). These limitations have encouraged researchers to identify safer and more effective alternatives from natural sources.

The global prevalence of renal dysfunction and fluid retention disorders has increased considerably during recent decades, mainly due to rising incidences of hypertension, obesity, diabetes mellitus, cardiovascular diseases, and metabolic syndrome (Rathod et al., 2021). Renal dysfunction may arise as a primary disorder or secondary complication of systemic diseases and significantly affects the body’s ability to regulate fluid balance, electrolyte concentration, acid-base equilibrium, and blood pressure. Disturbances in sodium and potassium levels often serve as early cynical indicators of impaired renal physiology and electrolyte imbalance. Therefore, effective management of fluid retention and electrolyte disturbances remains a major clinical challenge (Harrison et al., 2020).

Electrolytes such as sodium, potassium, chloride, magnesium, and bicarbonate are essential for maintaining cellular membrane potential, neuromuscular excitability, cardiovascular function, and endocrine activities (Kumar et al., 2020). Alterations in electrolyte levels are considered important biomarkers of renal dysfunction and systemic inflammatory conditions. Therefore, evaluation of diuretic agents should include parameters such as urine volume, urinary electrolyte excretion, serum electrolyte profile   and renal function markers (Chan et al., 2022). Recently, the concept of herbal or electrolyte-modulatory phytomedicine has attracted significant scientific attention because medicinal plant may regulate fluid balance while simultaneously providing nephroprotective and antioxidant effects.

Among the medicinal plants used for the management of renal disorders, Boerhavia diffusa Linn. (Punarnava) belongs to the family Nyctaginaceae and is highly valued in Ayurvedic medicine because of its broad range of therapeutic properties. Boerhavia diffusa grows naturally across many tropical and subtropical regions, including India, Africa, and several parts of Southeast Asian. Traditionally, Punarnava has been used for the treatment of renal diseases, edema, ascites, hepatosplenomegaly, urinary tract disorders, and in Ayurvedic medicine, it is considered a Rasayana herb with rejuvenating properties that help restore normal physiological functioning and improve overall health status.

Phytochemical investigations have shown that Boerhavia diffusa contains a broad spectrum of bioactive constituents, including punarnavine, boeravinones, flavonoids, lignans, rotenoids, glycosides, steroids, and phenolic compounds (Deshmukh et al., 2021). These phytochemicals are considered responsible for many of the plant^, s biological and therapeutic activities. Experimental studies have reported that the plant exhibits diuretic, anti-inflammatory, nephroprotective, hepatoprotective, antioxidant, and anti-edematous properties. In addition, Boerhavia diffusa has been found to improve renal blood flow, enhance glomerular filtration, and promote the urinary excretion of sodium and chloride while maintaining electrolyte balance. These findings support its traditional use in the management of renal disorders and related conditions (Raju et al., 2022).

Furthermore, the antioxidant activity of boerhavia diffusa may help reduce oxidative stress and may help reduce oxidative stress and protect renal tissues from inflammatory damage. Owing to its diverse pharmacological actions, rich phytochemical composition, ang comparatively favorable safety profile the plant gained considerable attention as a promising herbal therapeutic agent. Its traditional use, together with supportive experimental evidence, highlights its potential in the management of renal, hepatic, inflammatory, and metabolic disorders. Nevertheless, additional well-designed clinical studies are required to validate its therapeutic efficacy, establish standardized dosage regimens, and confirm its long-term safety in humans. Continued research on its scientific relevance and support the development of evidence-based herbal formulations and future pharmaceutical products.

Figure 1: Schematic overview illustrating the diverse pharmacological properties and therapeutic significance of Boerhavia diffusa (Punarnava), emphasizing its role as a potential natural therapeutic agent in modern healthcare.

Figure 3: illustrative summary of the phytochemical profile, biological activities, and therapeutic applications of Boerhavia diffusa (Punarnava) with emphasis on its medicinal potential.

Figure 2: Mechanism of diuretic action of Boerhavia diffusa linn. at various sites of nephron leading to increased urine output and therapeutic benefits.

5.2 Anti-inflammatory Activity

Inflammation is a major pathological process associated with several chronic diseases, and Boerhavia diffusa has been extensively investigated for its anti-inflammatory potential. Experimental studies have reported that ethanolic extracts of Punarnava significantly reduce acute and chronic inflammatory responses in different animal models. Subramanian and Kalaskar (1995) demonstrated that the extract effectively suppressed carrageenan-induced paw edema and cotton pellet granuloma formation in rats, indicating its ability to inhibit both acute and proliferative phases of inflammation. The anti-inflammatory activity is primarily associated with flavonoids, alkaloids, phenolic compound, and rotenoids, which reduce the production of inflammatory mediators and oxidative stress. Compared with conventional non- steroidal anti-inflammatory drugs (NSAIDs), Punarnava has shown a comparatively favorable safety profile with fewer gastrointestinal adverse effects (Goyal et al., 2000). These findings support its traditional use in arthritis, joint pain, edema, and other inflammatory disorders.

5.3 Hepatoprotective activity

The hepatoprotective potential of boerhavia diffusa has been confirmed in several experimental studies. Goyal et al. (1998) reported that the aqueous root extract significantly protected experimental animals against thioacetamide- induced liver injury. Treatment with the extract resulted in marked reductions in serum hepatic biomarkers, including AST (SGOT), ALT (SGPT), ALP and bilirubin, while improving the structural integrity of liver tissues. The hepatoprotective effect mainly attributed to the antioxidant properties of flavonoids, boeravinones and phenolic compounds, which minimize oxidative stress and stabilize hepatocyte membranes. In ayurvedic medicine, Punarnava has traditionally been prescribed for jaundice, hepatomegaly, and various liver disorders. Overall, available evidence indicates that boerhavia diffusa possesses significant hepatoprotective activity and may serve as a valuable herbal therapeutic agent for maintaining liver health and preventing hepatic damage.

5.4 Antidiabetic activity

Boerhavia diffusa linn. has gained considerable attention as a potential herbal antidiabetic agent because of its antihyperglycemic, antioxidant and metabolic^- regulatory properties. Recent evidence suggests that the plant possesses diverse bioactive constituents, including punarnavine, boeravinones, flavonoids, phenolic compounds, and alkaloids, which contribute to glucose homeostasis by enhancing insulin sensitivity, protecting pancreatic b-cells, and reducing oxidative stress. Das et al. (2023) comprehensively reviewed the pharmacological activities of Boerhavia diffusa and highlighted its promising antidiabetic potential emphasizing that its phytochemicals may regulate carbohydrate metabolism, improve insulin secretion and reduce diabetes^-associated oxidative damage.

Similarly, Rafi et al. (2025). Demonstrated that methanolic extract of Boerhavia diffusa produced a dose^-dependent reduction in blood glucose levels in streptozotocin-induced improvements in metabolic parameters, suggesting that the plant possesses considerable therapeutic potential for diabetes management.

Furthermore, Patel et al. (2025). Summarized available evidence and concluded that the antidiabetic activity of Boerhavia diffusa results from the synergistic action of multiple phytochemicals with antioxidant and anti-inflammatory properties. These compounds protect pancreatic b-cells from reaction oxygen species (ROS), improve glucose utilization, normalize lipid metabolism, and may reduce the risk of diabetic complications such as nephropathy and cardiovascular dysfunction. However, they also emphasized that additional well- designed clinical trials are necessary before routine therapeutic use in humans can be recommended.

5.5 Antioxidant Activity

Boerhavia diffusa Linn. is widely recognized for its remarkable antioxidant potential, which is primarily attributed to its abundance of phenolic compounds, flavonoids, rotenoids, alkaloids, lignans, and other bioactive phytochemicals. These constituents effectively neutralize reactive oxygen species (ROS) and reactive nitrogen species (RNS), thereby protecting cellular macromolecules such as DNA, proteins, and membrane lipids from oxidative damage. Oxidative stress plays a central role in the pathogenesis of diabetes mellitus,

Cardiovascular disorders, neurodegenerative diseases, chronic and cancer; therefore, natural antioxidant present in boerhavia diffusa have attracted considerable interest for their preventive and therapeutic potential.

According to Das et al. (2023), Boerhavia diffusa contains several potent antioxidant phytoconstituents, including punarnavoside, punarnavine, boeravinones (A-J), quercetin, kaempferol, boerhavic acid, trans-caftaric acid, b- ecdysone, and liriodendrin, which collectively enhance endogenous antioxidant defense mechanisms. These compounds increase the activity of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione (GSH) while simultaneously reducing lipid peroxidation and malondialdehyde (MDA) formation.

Recent reviews have further suggested that the antioxidant activity of Boerhavia diffusa contributes significantly to its nephroprotective, anti-inflammatory, and antidiabetic effects by minimizing oxidative injury, preserving mitochondrial integrity, and regulating inflammatory signaling pathways. The synergistic interaction among multiple phytochemicals provides broader pharmacological benefits than individual isolated compounds. Consequently, Boerhavia diffusa represents a promising natural source of antioxidants for preventing oxidative stress- mediated disorders, although further clinical investigation is required to validate its long-term efficacy and safety in humans.

5.6 Anti-arthritic activity

Boerhavia diffusa Linn. has emerged as a promising medicinal plant for the management of inflammatory joint disorders because of its potent anti-inflammatory, antioxidant, and immunomodulatory properties. Rheumatoid arthritis is characterized by chronic synovial inflammation, excessive production of pro-inflammatory cytokines, oxidative stress, and progressive destruction of cartilage and bone. Bioactive constituents of punarnavine, flavonoids, and phenolic compounds, have been reported to interfere with these pathological processes by suppressing inflammatory mediators and protecting joint tissues against oxidative injury.

Das et al. (2023) highlighted that the anti-arthritic activity of boerhavia diffusa is mediated through inhibition of inflammatory cytokines such as tumor necrosis factor-alpha (TNF-), interleukin-1B (IL-1B), interleukin-6 (IL-6), cyclooxygenase (COX), and prostaglandin synthesis. In addition, the antioxidant constituents reduce oxidative stress by scavenging free radicals and restoring endogenous antioxidant enzyme activity, thereby minimizing cartilage degeneration and improving joint function.

Earlier experimental studies demonstrated significant reduction in paw edema, inflammatory cell infiltration, and joint swelling in rats with arthritis induced by Freund s complete adjuvant (FCA) following treatment with Boerhavia diffusa root extract. Recent reviews continue to support these findings and emphasize that its multi-target pharmacological actions make it a promising complementary arthritis. However, current evidence is largely preclinical, and well-designed randomized clinical trials are still needed to confirm its efficacy, optimal dosage, and long- term safety in patients with rheumatoid arthritis.

5.7 Antimicrobial activity

Experimental studies indicate that Boerhavia diffusa Linn. possesses broad^- spectrum antimicrobial activity against a wide range of pathogenic microorganisms. Experimental studies suggest that extracts of the plant possess inhibitory effects against both gram-positive and Gram-negative bacteria, thereby supporting its traditional use in the management of infectious diseases (Goyal et al., 2007). The antimicrobial effects of boerhavia diffusa bioactive constituents, including punarnavine, boeravinones, flavonoids, phenolic compounds, and alkaloids, which interfere with bacterial cell wall integrity, alter membrane permeability and inhibit essential microbial enzymes. In traditional medicine, Punarnava has been widely employed for the treatment of skin infections, wound infection, and urinary tract infection. In addition, its antioxidant and anti-inflammatory activities may facilitate tissue repair while reducing inflammation associated with microbial infections, making the plant a promising natural antimicrobial agent.

5.8 Antistress, Adaptogenic and Immunomodulatory Activity

Boerhavia diffusa Linn. has been extensively investigated for its adaptogenic, antistress, and immunomodulatory properties. Traditional Ayurvedic medicine recognizes Punarnava as a rejuvenating herb capable of improving the ability of the body to adapt to physical, chemical, and psychological stressors. Resistance to physical, chemical, and psychological stress. Kulkarni et al. (2003) reported that hydroalcoholic extracts of boerhavia diffusa effectively normalized stress- induced biochemical alterations in cold- restraint stress models. Treatment significantly reduced elevated blood glucose, serum triglycerides and cholesterol levels while improving the physiological stress response. The adaptogenic activity is primarily associated with flavonoids, alkaloids, and phenolic compounds, which reduce oxidative stress and maintain cellular homeostasis. Furthermore, the plant has demonstrated immunomodulatory effects by regulating immune cell function and strengthening the traditional use of Punarnava as a natural adaptogen for improving stress tolerance, enhancing immunity, and restoring metabolic balance.

5.9 Nephroprotective activity

Boerhavia diffusa Linn. has been extensively investigated for its nephroprotective potential and is traditionally used in Ayurveda for the treatment of kidney disorders, urinary tract infections, nephrolithiasis, edema and fluid retention. Recent pharmacological investigations suggest that the nephroprotective effects of boerhavia diffusa are mainly associated with its bioactive constituents, including punarnavine, boeravinones, flavonoids, alkaloids, phenolic compounds, and lignans, which collectively exhibit antioxidant, anti-inflammatory, and diuretic properties. Das et al. (2023) reported that these phytochemicals effectively reduce oxidative stress by scavenging reactive oxygen species (ROS), enhancing endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH), and protecting renal tissues from cellular damage. In addition, Santhosh et al. (2023). Observed that Boerhavia diffusa significantly improved renal function by lowering serum creatinine, blood urea nitrogen (BUN), and urinary protein levels while maintaining electrolyte balance and increasing urine output. The combined antioxidant, anti-inflammatory, and diuretic actions contribute to the preservation of normal renal architecture, improved glomerular filtration, and enhanced elimination of metabolic waste products. These findings indicate that Boerhavia diffusa is a promising herbal candidate for protecting renal function and supporting the management of acute and chronic kidney disorders. Nevertheless, additional well- designed clinical investigations are necessary to determine the optimal dosage, evaluate long- term safety, and confirm therapeutic efficacy in human subjects.

6. PHYTOCHEMISTRY

Punarnava, boerhavia diffusa Linn. is a widely used Ayurvedic and folk medicine and in a medicinally significant plant of family Nyctaginaceae. The medicinal importance of this plant is primarily associate with its wide range of bioactive phytochemicals. Phytochemical investigations have demonstrated that B. diffusa contains numerous bioactive constituents, including alkaloids, flavonoids, phenolic compounds, rotenoid, steroid, terpenoid, lignan, glycoside and other secondary metabolites. The distribution of these phytoconstituents varies among different parts of the plant, such as the roots, leaves, stems, and whole-plant extracts, thereby contributing to its diverse pharmacological properties.

Among other classes of phytochemicals, alkaloids are regarded as being among the most important constituents of boerhavia diffusa. The key alkaloid that is documented in the plant is Punarnavine has been extensively studied because of its reported diuretic, anti-inflammatory, hepatoprotective, and immunomodulatory activities. The punarnavine is found predominantly in the roots and the aerial parts. Other compound that has been reported to contain nitrogen include; hypoxanthine and alkaloidal derivatives of punarnavine. In traditional medicine, Punarnava has long been employed for the management of urinary tract infections, edema, and various kidney disorders.

Rotenoids are distinct and characteristic phytochemicals in Boerhavia diffusa. Several rotenoid compounds, including boeravinones A-J, have been identified in Boerhavia diffusa, with the roots representing the principal source of these phytochemicals. These are regarded as significant chemotaxonomic species markers. Boeravinones have been reported to exhibit antioxidant, hepatoprotective, anti-inflammatory, and anticancer properties. These rotenoids reinforce the conventional application of Punarnava in liver ailments and detox solutions. The rotenoids of B. diffusa have a high biological potential and hence have drawn significant attention in recent study of phytochemical and pharmacological research studies.

Another large group of phytoconstituent found in Boerhavia diffusa is flavonoids. The plant has been found to contain different flavonoids such as quercetin and kaempferol their glycosidic counterparts in the leaves and stems. These are compounds well known in terms of antioxidant and free radical scavenging properties. The high flavonoid content is considered to contribute significantly to the anti-inflammatory effects, hepatoprotective and cardioprotective effects of the plant. The protective effects against oxidative stress induced cellular damage are also achieved by flavonoid, thereby further justifying the use of Punarnava in chronic inflammatory and metabolic diseases.

Boerhavia diffusa contains abundant phenolic compounds and glycosides. Notable phenolic compounds reported are punarnavoside, trans-caftaric acid, eupalitin and eupalitin-3-O-2 -galactopyranoside. Strong antioxidant activity is attributed to these phenolic compounds which neutralize reactive oxygen species (ROS) and inhibit lipid peroxidation. The quantitative phytochemical research that was conducted has revealed that the root extracts of B. diffusa have higher total phenolic and flavonoid contents than aerial parts. These phenolic compounds exhibit antioxidant effect, which adds to the protective action of the plant in liver, kidney and cardiovascular ailments.

Boerhavia diffusa contains other important phytochemical constituents, including steroids and terpenoids. The major phytosterols identified in the roots and the whole plant include b-sitosterol, stigmasterol and boerhavisterol. These are the compounds that have anti-inflammatory, immunomodulatory and hypolipidemic effects. The presence of terpenoid constituents also increases the therapeutic properties of the plant by adding to its adaptogenic and anti-stress action. These compounds validate the old assertions that Punarnava is a rejuvenating and strengthening herb.

Another important group of phytochemicals includes lignans and lignan glycosides. Lignan glycosides such as liriodendrin and syringaresinol mono-b-D-glucoside have been isolated and have been reported to exhibit calcium channel- blocking activity, antioxidant, and organ^- protective properties. In addition, the plant also has saponins, carbohydrates, proteins, amino acids, fatty acids and inorganic minerals which contribute to the   nutritional and medicinal value of the plant

7. TOXICITY AND SAFETY PROFILE

Boerhavia diffusa Linn. (Punarnava) has been extensively used in traditional Ayurvedic medicine for centuries and is generally regarded as a medicinal plant with a favorable safety profile when consumed at recommended therapeutic doses. The safety of the plant is mainly attributed to its naturally occurring phytoconstituents, including punarnavine, boeravinones, flavonoids, phenolic compounds, alkaloids, lignans, and glycosides, which exhibit therapeutic efficacy with minimal toxic effects. Recent reviews by Das et al. (2023) have reported that extracts of Boerhavia diffusa did not produce significant acute or sub-chronic toxicity in experimental animals when administered within the recommended therapeutic dose range. Similarly, Mondal et al. (2024) emphasized that standardized extracts of Punarnava were well tolerated and did not cause significant alterations in liver enzymes, renal function markers, hematological parameters, or histopathological architecture of major organs. In addition, the antioxidant and anti-inflammatory activities of the plant may protect tissues from oxidative and inflammatory damage during prolonged therapeutic use. However, Patel et al. (2025) concluded that although the safety of boerhavia diffusa has been demonstrated in several preclinical studies, further investigations on chronic toxicity, reproductive toxicity, genotoxicity, herb-drug interactions, and well- controlled clinical trials are still required to establish its long-term safety and therapeutic efficacy in humans. Overall, the available evidence indicates that boerhavia diffusa is a comparatively safe medicinal plant with promising therapeutic potential, provided that authenticated plant material, standardized formulations, and appropriate dosage regimens are used.

8. FUTURE PERSPECTIVES

Boerhavia diffusa Linn. (Punarnava) has emerged as a promising medicinal plant because of its rich phytochemical profile and diverse pharmacological properties. Although boerhavia diffusa shown a wide range of pharmacological effects, including diuretic, nephroprotective, hepatoprotective, anti-inflammatory, antioxidant, antidiabetic, and immunomodulatory activities in experimental studies, the majority of the current evidence is derived from in vitro investigations and animal models rather than human clinical trials. Recent reviews by Das et al. (2023) and Patel et al. (2025) emphasized the need for well-designer randomized clinical trial to confirm the efficacy, safety, and therapeutic benefits of boerhavia diffusa in human subjects. Future research should focus on the isolation and characterization of novel bioactive phytoconstituents, elucidation of their molecular mechanisms of action, pharmacokinetic and pharmacodynamic profiling, and the development of well- standardized herbal formulations with consistent quality and reproducible therapeutic outcomes. In addition, advanced approaches such as molecular docking, nanotechnology-based drug delivery systems, and multi-target pharmacological investigations may further enhance the clinical applications of boerhavia diffusa. Establishing international quality-control standards, dose optimization, long-term toxicity evaluation together with detailed herb-drug interaction studies will also be essential to establish its safety and therapeutic effectiveness for clinical use. Overall, continued multidisciplinary research integrating traditional Ayurvedic knowledge with development of boerhavia diffusa as an evidence- based herbal medicine for the prevention and management of renal, metabolic, inflammatory, and other chronic disorders.

CONCLUSION

Boerhavia diffusa Linn. (Punarnava) is a well- recognized medicinal herb in Ayurveda that has attracted considerable scientific interest owing to its diverse phytochemical profile and range of pharmacological activities. The available evidence demonstrates that the plant possesses significant diuretic, nephroprotective, hepatoprotective, antioxidant, anti-inflammatory, antidiabetic, antimicrobial, anti-arthritic, and immunomodulatory effects, which are mainly attributed to bioactive constituents such as punarnavine, boeravinones, flavonoids, phenolic compounds, alkaloids, lignans, and glycosides. Diuretic activity remains one of the most extensively investigated therapeutic properties and plays an important role in the management of edema, hypertension, urinary tract disorders, nephrolithiasis, and dysfunction by promoting urine output while maintaining electrolyte balance. Experimental studies have consistently supported the traditional medicinal use of safe Punarnava and indicate its potential as a safe and effective herbal therapeutic agent. Nevertheless, despite encouraging preclinical findings, additional well- designed clinical trial, standardized formulations, pharmacokinetic investigation, and long-term safety evaluation are still required to establish its clinical efficacy and optimize its therapeutic application in humans. Overall, Boerhavia diffusa represents a promising natural source of bioactive compounds with significant potential for evidence- based herbal medicines and future pharmaceutical applications, warranting further clinical and pharmacological investigations.

REFERENCES

1. Vijay, P., Kumar, R., & Singh, S. Antioxidant and free radical scavenging activity of Boerhavia diffusa L. Journal of Pharmacognosy and Phytochemistry. 2014; 3(2), 178–182.
2. Apurva, A., Patel, N., & Shah, B. Phytochemical screening and pharmacological potential of Boerhavia diffusa. International Journal of Pharmaceutical Sciences and Research. 2018; 9(6), 2456–2462.
3. Kafaru E. Immense help from Natives workshop.1st edition Lagos (Nigeria): Elizabeth Kafaru;1994. p. 11-14.
4. Aravind, G., Bhowmik, D., Duraivel, S., & Harish, G. Traditional and medicinal uses of Boerhavia diffusa Linn. Journal of Medicinal Plants Studies.2013; 1(1), 1–7.
5. George, M., Joseph, L., & Rajesh, R. Diuretic activity of ethanolic extract of Boerhavia diffusa roots. Indian Journal of Pharmacology.2014; 46(5), 567–571.
6. Williams, B.R., Davis, K.L., & Chen, P. Electrolyte disturbances associated with prolonged diuretic therapy: Mechanisms and clinical management. Clinical Nephrology Journal.2022; 28(2), 98–113.
7. Harrison, DL., 21Carter, EJ, & Benson, M. Therapeutic role of diuretics in renal and cardiovascular disorders: Mechanistic and clinical perspectives. International Journal of Clinical Pharmacology. 2020;27(3)176–189.
8. Rathod, SK., Shinde, M.R. Global rise of renal disorders and associated metabolic   complications: A statistical overview. Journal of Renal Medicine & Research. 2021;14(1), 1–12.
9. Ravindran, AR., Joseph, M., & Alex, K. Comparative evaluation of synthetic and herbal diuretics: Safety issues and future prospects. Journal of Ethnopharmacology Studies.2023; (3), 207–221.
10. Kumar, M., Jain, P., & Lavania, S. Physiological significance of electrolytes in cellular function and systemic homeostasis. Indian Journal of Physiology and Pharmacology.2020; 64(1), 55–68.
11. Chan, XH., Lim, PY., & Morgan, T.  Electrolyte biomarkers as diagnostic indicators of renal dysfunction: A comprehensive review. Journal of Nephrology and Therapeutics.2022; 18(4), 245–259.
12. Deshmukh, P.R., Almeida, R., & Kurian, J. (2021). Phytochemical and pharmacological evaluation of Boerhavia diffusa root extract with emphasis on nephroprotective activity. Phytomedicine Research. 2021; 9(2), 89–102.
13. Raju, K.S., Priyanka, S., & Venkataraman, S. (2022). Antioxidant and nephroprotective effects of Boerhavia diffusa: Experimental evidence and therapeutic insights. Research Journal of Pharmacology, 16(2), 112–124.
14. Singh A., Pandey V., & Tiwari M. immunomodulatory activity of boerhavia diffusa. Pharmacognosy research. 2011; 3(4), 259-263.
15. Jain A., & Khare S.  Anti- stress activity of boerhavia diffusa roots. International journal of pharmacy and pharmaceutical Sciens, 2015;7(3), 123-126.
16. Singh R.H., & Udupa KN. Studies on Punarnava (Boerhavia diffusa). Journal of Punarnava (Boerhavia diffusa). Journal of Research in Indian Medicine.1972; 7, 28-33.
17. Pandey R., & Mishra A. Analgesic anti-inflammatory activity of Boerhavia diffusa. International journal of pharmaceutical sciences Review and research.2012; 14(2), 120-124.
18. Sharma p., & Joshi S.C (2013). Nephroprotective effect of boerhavia diffusa roots. Journal of herbal medicine, 3(2), 74-79.
19. World health organization quality control methods for herbal Materials. Geneva: world Health Organization; 2011.
20. Rafi MNH, et al. A pharmacological investigation of boerhavia diffusa: anticancer, Properties. J Pharm Res Int. 2025; 37(5):1-15
21. Mondal S, et al.” Punarnava “(boerhavia diffusa): An Ancient herbal medicine with the emphasis of Ayurda on its therapeutic potential. Current Indian science. 2024; 2:1-15. 
22. Patel, G., Sharma, H., & Ramesh, K. (2023). Electrolyte-modulating effects of medicinal plants with diuretic properties: A systematic assessment. Journal of Herbal Pharmacotherapy .2023; 12(1), 41–59.
23. Bairwa K, Jachak SM. Anti-inflammatory potential of a lipid-based formulation of a rotenoid-rich fraction prepared from Boerhavia diffusa. Pharm Biol. 2015;53(8):1231–1238.
24. Nayak P, Thirunavukkarasu M. A review of the plant Boerhavia diffusa: Its chemistry, pharmacology and therapeutic potential. J Phytopharmacology. 2016;5(2):83–92.
25.  Mishra S, Aeri V, Gaur PK, Jachak SM. Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn. Biomed Res Int. 2014; 2014:808302.
26. Mun antiwar AA, Nair AM, Shinde UA, et al. Studies on the immunomodulatory effects of Boerhavia diffusa alkaloidal fraction. J Ethnopharmacology. 1999;65(2):125–131.
27. Yadav NP, Dixit VK. Hepatoprotective activity of Boerhavia diffusa. Indian J Pharm Sci. 2010;72(5):560–564.
28. Lami N, Kadota S, Kikuchi T, Momose Y. Constituents of Boerhavia diffusa. Chem Pharm Bull (Tokyo). 1991;39(6):1551–1555.
29. Bhowmik D, Kumar KPS, Srivastava S, Paswan S, Dutta AS. Traditional Indian herbs Punarnava and its medicinal importance. J Pharmacognosy Phytochemical. 2012; 1:52–57.
30. OECD Principles of Good Laboratory Practice (GLP). OECD Series on Principles of Good Laboratory Practice and compliance.
31. Das S, Singh PK, Ameeruddin S, Bindhani BK, Obaidullah WJ, Obaidullah AJ, Mishra S, Mohapatra RK. Ethnomedicinal values of Boerhavia diffusa L. as a panacea against multiple human ailments: a state of art review. Front Chem. 2023; 11:1297300
32. World Health Organization. WHO Monographs on Selected Medicinal Plants. Vol. 2. Geneva: World Health Organization; 2002.
33. Anonymous. The Ayurvedic Pharmacopoeia of India. Part I, Vol. I. New Delhi: Ministry of AYUSH, Government of India; 2001.
34. Anonymous. The Wealth of India: A Dictionary of Indian Raw Materials and Industrial Products. Vol. 2. New Delhi: CSIR; 1988.
35. Nadkarni KM. Indian Materia Medica. 3rd ed. Mumbai: Popular Prakashan; 2007.
36. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants Used in Ayurveda. Vol. 5. New Delhi: CCRAS; 2008.
37. Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. New York: Springer; 2007.
38. Prajapati ND, Purohit SS, Sharma AK, Kumar T. A Handbook of Medicinal Plants. Jodhpur: Agrobios; 2003Awasthi LP, Verma HN. Boerhavia diffusa – A wild herb with potent biological and antimicrobial properties. Asian Agric Hist. 2006;10(1):55–68.
39. Rawat AKS, Mehrotra S, Tripathi SC, Shome U. Hepatoprotective activity of Boerhavia diffusa L. roots. J Ethnopharmacol. 1997;56(1):61–66.
40. Mehta, R, & Joshi, V. (2021). Adjunctive use of herbal extracts with loop diuretics: effects on Electrolyte handling. Indian journal of Pharmacology, 53(3): 189-196
41. Chandan BK, Sharma AK, Anand KK. Protective effect of Boerhavia diffusa against experimentally induced liver injury. Indian J Exp Biol. 1991;29(12):1162–1163.
42. Hiruma-Lima CA, Gracioso JS, Bighetti EJ, Germonsén-Robineau L, Souza Brito AR. The juice of Boerhavia diffusa roots reduces experimental gastric ulceration. J Ethnopharmacol. 2000;71(3):469–473.
43. Olaleye MT, Rocha JBT. Commonly used medicinal plants: Boerhavia diffusa and its antioxidant properties. Food Chem Toxicol. 2008;46(6):2080–2085.
44.  RAO, V, et al. (2018). Evaluation of diuretic activity of Boerhavia Diffusa root extract in experimental animals. Indian Journal of experimental biology, 56(7): 459-466.
45. Borrelli F, Izzo AA. The plant kingdom as a source of anti-inflammatory remedies. Phytotherapy Res. 2000;14(8):581–591.
46.  Sahu AN, Damiki L, Nilanjan G, Dubey SD. Phytopharmacological review of Boerhavia diffusa Linn. Pharmacognosy Rev. 2008;2(4):14–22.
47.  Aftab K, Usman Ghani K, Ahmad M. Pharmacological studies on Boerhavia diffusa. Fitoterapia. 1996;67(5):393–397.
48.  Chandan BK, Sharma AK, Anand KK. Boerhavia diffusa: Experimental evaluation of hepatoprotective activity. J Ethnopharmacol. 1991;31(3):299–307.
49.  Singh RH, Udupa KN. Clinical and experimental studies on Punarnava. J Res Indian Med. 1972; 7:28–33.
50. Ahmed-Belkacem A, et al. Ethnomedicinal uses, phytochemistry and pharmacological properties of the genus Boerhavia. J Ethnopharmacol. 2016; 189:10–33.
51.  Bhalerao SA. Ethnobotanical, phytochemical and pharmacological profile of Boerhavia diffusa Linn.: A review. Asian J Chem. 2012;24(12):5727–5730.
52. 105. Santhosh S, Pazhani GP, Arathi MS, Manickam S. Nephroprotective role of Boerhavia diffusa in renal disorders: A review. Res J Pharm Technol. 2023;16(2):962–
53. Gaitonde BB, Kulkarni HJ, Nabar SD. Diuretic activity of medicinal plants used in Ayurveda. Indian J Med Res. 1974; 62:564–567.
54. Patel BR, Patel MR. Pharmacological evaluation of Boerhavia diffusa root extract. Pharmacognosy J. 2013;5(6):276–281.
55.  Gupta M, Mazumder UK. Evaluation of antioxidant potential of Boerhavia diffusa. Indian Drugs. 2004;41(5):264–267. Patel N, Mishra R, Rajput D, Gupta A. A comprehensive review of the phytochemistry, pharmacology, pharmacokinetics, and green nanotechnological significance of Boerhavia diffusa Linn. Fitoterapia. 2025; 184:106599.
56.  Correlation between phytocompounds and pharmacological activities of Boerhavia diffusa Linn. with traditional ethnopharmacological insights. J Ayurveda Integer Med. 2022.
57. Kumar R, Gautam S, Singh KD, et al. Pharmacological properties of Boerhavia diffusa: A review. Int J Chem Stud. 2018;6(Special Issue 4):72–80.
58. Singh A, Singh PK. Nephroprotective effect of Boerhavia diffusa in experimental animals. Pharmacology online. 2012; 2:425–434.
59. Rawat AKS. Medicinal importance and phytochemistry of Punarnava (Boerhavia diffusa Linn.). J Med Aromata Plant Sci. 2002; 24:102–107.
60. Meena AK, Niranjan US, Yadav AK, Rao MM. A review on Boerhavia diffusa: Traditional uses, phytochemistry and pharmacology. Int J Pharm Sci Rev Res. 2010;3(1):151–156.
61.  Cowan MM. Plant products as antimicrobial agents. Clin Microbial Rev. 1999;12(4):564–582.
62.  Ekor M. The growing use of herbal medicines: Benefits and safety concerns. Front Pharmacal. 2014; 4:177.
63.  Pan SY, Litscher G, Gao SH, et al. Historical perspective of traditional indigenous medical practices: The current renaissance and conservation of herbal resources. Evid Based Complement Alternat Med. 2014; 2014:525340.
64.  Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine. 2001;8(5):401–409.
65.  Pandey MM, Rastogi S, Rawat AKS. Indian traditional Ayurvedic system of medicine and nutritional supplementation. Evid Based Complement Alternat Med. 2013; 2013:376327.
66. Gupta AK, Tandon N, Sharma M. Quality Standards of Indian Medicinal Plants. Vol. 2. New Delhi: Indian Council of Medical Research; 2005.
67. Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. Vol. 3. Dehradun: International Book Distributors; 1999.
68. Evans WC. Trease and Evans' Pharmacognosy. 16th ed. London: Saunders Elsevier; 2009.
69. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 56th ed. Pune: Nirali Prakashan; 2021.
70. Wallis TE. Textbook of Pharmacognosy. 5th ed. New Delhi: CBS Publishers & Distributors; 200
71. World Health Organization. WHO Monographs on Selected Medicinal Plants. Vol. 2. Geneva: World Health Organization; 2002.
72. Anonymous. The Ayurvedic Pharmacopoeia of India. Part I, Vol. I. New Delhi: Ministry of AYUSH, Government of India; 2001.
73. Anonymous. The Wealth of India: A Dictionary of Indian Raw Materials and Industrial Products. Vol. 2. New Delhi: CSIR; 1988.
74. Nadkarni KM. Indian Materia Medica. 3rd ed. Mumbai: Popular Prakashan; 2007.
75. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants Used in Ayurveda. Vol. 5. New Delhi: CCRAS; 2008.
76. Science Open Review. Nephroprotective role of Boerhavia diffusa in renal disorders. Res J Pharm Technol. 2023.
77. Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. New York: Springer; 2007.
78. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. New Delhi: CSIR; 1956.
79. The Ayurvedic Pharmacopoeia of India. Part I, Vol. II. New Delhi: Ministry of Ayush, Government of India; 2008.